Home About Clinical Research News Insights Podcasts Videos SCOPE Events

Stay Connected to Clinical Research—All Year Long

SCOPE 365 is the year-round digital extension of SCOPE, bringing clinical research professionals continuous access to insights, live virtual meetups, expert interviews, and premium intelligence products. It’s a centralized hub designed to help sponsors, CROs, sites, and solution providers stay on the pulse of the industry, elevate thought leadership, and maintain momentum between SCOPE’s global conferences.

Latest In Clinical Trials

Data is Both the Fuel and Downfall of AI in Drug Development

Clinical Research News | High-impact opportunities for leveraging AI across the pharmaceutical R&D cycle are too numerous to count but won’t “automagically” solve any of the longstanding problems in ushering molecules to market. AI requires human attention to match tools to tasks for ensuring the accuracy of model predictions, and the pitfalls are dangerously easy to miss, according to a Novo Nordisk presentation at this week’s Scope X conference in Boston. more...

May 21, 2026
Bacteria: Unsung Players in the Tumor Microbiome

Clinical Research News | How cancer patients will respond to treatment can be anticipated based on their genetics as well as the tumor microenvironment, although one relevant component is often all but dismissed: the tumor microbiota. This is despite an abundance of evidence that a cancer’s microbial community plays a major role not only in therapeutic effects but also in tumor development, progression, and metastasis formation. more...

May 20, 2026
Is Your AI Delivering Real Business Value? Here's How to Know

Insights from SCOPE | AI in clinical development is shifting from experimentation to measurable business impact. Explore where artificial intelligence is truly driving value across startup, enrollment, governance, and portfolio strategy — and why strong data foundations and oversight determine long-term success. more...

May 19, 2026
FDA Conversation on Selective Safety Data Collection

Clinical Research News | Earlier this month, TransCelerate BioPharma released a summary report focused on selective safety data collection (SSDC) gathered during a joint tabletop exercise convened in late 2025 in collaboration with U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) Center for Clinical Trial Innovation (C3TI). more...

May 19, 2026
Key Questions Every Clinical Leader Should Be Asking About AI in 2026

Insights from SCOPE | Clinical leaders are moving beyond AI experimentation and into real operational decisions. Explore five strategic questions that will shape how artificial intelligence transforms clinical trial design, execution, governance, and human oversight in 2026 and beyond. more...

May 14, 2026
23andMe: How Genetics Contribute to GLP-1 Drug Outcomes

Clinical Research News | An engaged research cohort of over 11 million genotyped individuals has enabled 23andMe to produce a library of more than 300 peer-reviewed publications over the past 16 years. Following a 2025 bankruptcy filing, when it reemerged as a nonprofit medical research organization, the focus has settled on providing individuals with access to their genetic information, supporting genetics education, and studies that provide a deeper understanding of human genetics. more...

May 13, 2026